Publications by authors named "Johan Linderoth"

Claim this Profile
B
Brentuximab vedotin monotherapy is a feasible and effective treatment for older patients with classical Hodgkin lymphoma unsuitable for curative chemotherapy: Results from the prospective GHSG-NLG phase II BVB trial.
Alexander Fosså, Daniel Molin, Paul J Bröckelmann, Gundolf Schneider, Ulf Schnetzke, Johan Linderoth

Hemasphere· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The dual role of CD70 in B-cell lymphomagenesis.
Man Nie, Weicheng Ren, Xiaofei Ye, Mattias Berglund, Xianhuo Wang, Johan Linderoth

Clin Transl Med· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-world data on treatment concepts in classical Hodgkin lymphoma in Sweden 2000-2014, focusing on patients aged >60 years.
Björn Engelbrekt Wahlin, Ninja Övergaard, Stefan Peterson, Evangelos Digkas, Ingrid Glimelius, Johan Linderoth

EJHaem· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
No excess long-term mortality in stage I-IIA Hodgkin lymphoma patients treated with ABVD and limited field radiotherapy.
Ingemar Lagerlöf, Harald Holte, Ingrid Glimelius, Magnus Björkholm, Gunilla Enblad, Johan Linderoth

Br J Haematol· March 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nodular lymphocyte predominant Hodgkin lymphoma in Sweden between 2000 and 2014: an analysis of the Swedish Lymphoma Registry.
Daniel Molin, Johan Linderoth, Björn E Wahlin

Br J Haematol· May 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Estrogen receptor β1 in diffuse large B-cell lymphoma growth and as a prognostic biomarker.
Muhammad Sharif Hasni, Mattias Berglund, Konstantin Yakimchuk, Jiyu Guan, Johan Linderoth

Leuk Lymphoma· February 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
No survival benefit associated with routine surveillance imaging for Hodgkin lymphoma in first remission: a Danish-Swedish population-based observational study.
Lasse H Jakobsen, Martin Hutchings, Peter de Nully Brown, Johan Linderoth, Karen J Mylam

Br J Haematol· April 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Gene expression profiling indicates that immunohistochemical expression of CD40 is a marker of an inflammatory reaction in the tumor stroma of diffuse large B-cell lymphoma.
Karin Rydström, Patrick Joost, Mats Ehinger, Patrik Edén, Mats Jerkeman, Johan Linderoth

Leuk Lymphoma· September 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inhibition of geranylgeranylation mediates sensitivity to CHOP-induced cell death of DLBCL cell lines.
Malin Ageberg, Karin Rydström, Ola Lindén, Johan Linderoth, Mats Jerkeman

Exp Cell Res· May 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CD40 is a potential marker of favorable prognosis in patients with diffuse large B-cell lymphoma treated with immunochemotherapy.
Karin Rydström, Johan Linderoth, Heidi Nyman, Mats Ehinger, Patrick Joost

Leuk Lymphoma· September 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identification of molecular targets associated with transformed diffuse large B cell lymphoma using highly purified tumor cells.
Ulrika Andréasson, Michael Dictor, Mats Jerkeman, Mattias Berglund, Christer Sundström, Johan Linderoth

Am J Hematol· December 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
BCL2 expression in de novo diffuse large B-cell lymphoma partly reflects normal differences in age distribution.
Ulf Thunberg, Rose-Marie Amini, Johan Linderoth, Göran Roos, Gunilla Enblad

Br J Haematol· September 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Genes associated with the tumour microenvironment are differentially expressed in cured versus primary chemotherapy-refractory diffuse large B-cell lymphoma.
Johan Linderoth, Patrik Edén, Mats Ehinger, Jeanette Valcich, Mats Jerkeman

Br J Haematol· May 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A subset of CD5- diffuse large B-cell lymphomas expresses nuclear cyclin D1 with aberrations at the CCND1 locus.
Mats Ehinger, Johan Linderoth, Birger Christensson, Birgitta Sander, Eva Cavallin-Ståhl

Am J Clin Pathol· April 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Protein expression and cellular localization in two prognostic subgroups of diffuse large B-cell lymphoma: higher expression of ZAP70 and PKC-beta II in the non-germinal center group and poor survival in patients deficient in nuclear PTEN.
Marie Fridberg, Anna Servin, Lola Anagnostaki, Johan Linderoth, Mattias Berglund

Leuk Lymphoma· November 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CD40 expression identifies a prognostically favourable subgroup of diffuse large B-cell lymphoma.
Johan Linderoth, Mats Ehinger, Mats Jerkeman, Pär-Ola Bendahl, Måns Akerman

Leuk Lymphoma· September 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tissue microarray is inappropriate for analysis of BCL6 expression in diffuse large B-cell lymphoma.
Johan Linderoth, Mats Ehinger, Måns Akerman, Eva Cavallin-Ståhl, Gunilla Enblad

Eur J Haematol· August 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of immunophenotype in diffuse large B-cell lymphoma and its impact on prognosis.
Mattias Berglund, Ulf Thunberg, Rose-Marie Amini, Majlis Book, Göran Roos, Johan Linderoth

Mod Pathol· August 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immunohistochemical expression of CD23 and CD40 may identify prognostically favorable subgroups of diffuse large B-cell lymphoma: a Nordic Lymphoma Group Study.
Johan Linderoth, Mats Jerkeman, Eva Cavallin-Ståhl, Stein Kvaløy, Emina Torlakovic

Clin Cancer Res· February 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis